Literature DB >> 10879734

Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast.

C Jones1, M P Foschini, R Chaggar, Y J Lu, D Wells, J M Shipley, V Eusebi, S R Lakhani.   

Abstract

Although there seems to be a common stem cell for the two epithelial cell types in the breast, the vast majority of breast cancers exhibit a luminal phenotype. Pure myoepithelial carcinomas are rare. We report our findings of genetic alterations in these tumors. We have analyzed 10 cases of pure myoepithelial cell carcinomas using laser capture microdissection and comparative genomic hybridization. The mean number of changes was 2.1 (range 0-4), compared with a mean of 8.6 (range 3.6-13.8) in unselected ductal carcinomas. Common alterations included loss at 16q (3/10 cases), 17p (3/10), 11q (2/10), and 16p (2/10), regions also commonly deleted in ductal carcinomas. The single case in which both pure myoepithelial carcinoma and invasive ductal carcinoma was present showed 2 alterations in the myoepithelial tumor (losses at 17p and 17q), whereas the invasive ductal component showed 15 alterations (5 gains and 9 losses), including loss at 17p. The sharing of 17p loss in myoepithelial and ductal carcinoma is consistent with a common stem cell model in the breast. The relatively few genetic alterations in otherwise aggressive neoplasms suggests that myoepithelial tumors may be a good model for the delineation of genes important in breast tumorigenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10879734     DOI: 10.1038/labinvest.3780087

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Malignant adenomyoepithelioma of the breast metastasizing to the liver.

Authors:  Chris Jones; Reuben Tooze; Sunil R Lakhani
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

2.  [Salivary gland-like tumors of the breast].

Authors:  F Otterbach; K W Schmid
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 3.  Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Authors:  Catherine Clarke; Jennifer Sandle; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.673

4.  Mutation of the murine Bloom's syndrome gene produces global genome destabilization.

Authors:  Nicholas Chester; Holger Babbe; Jan Pinkas; Charlene Manning; Philip Leder
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Primary myoepithelial carcinoma of palate.

Authors:  Juan Ren; Zi Liu; Xiaoping Liu; Yi Li; Xiaozhi Zhang; Zongfang Li; Yunyi Yang; Ya Yang; Yuanyuan Chen; Shiwen Jiang
Journal:  World J Surg Oncol       Date:  2011-09-14       Impact factor: 2.754

6.  Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases.

Authors:  Natalia Buza; Nazila Zekry; Colette Charpin; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2010-07-24       Impact factor: 4.064

Review 7.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  Chromosomal changes in aggressive breast cancers with basal-like features.

Authors:  Wayne Yu; Yasmine Kanaan; Young Kyung Bae; Young-Kyung Baed; Edward Gabrielson
Journal:  Cancer Genet Cytogenet       Date:  2009-08

Review 9.  Laser capture microdissection and advanced molecular analysis of human breast cancer.

Authors:  Andrew P Fuller; Darryl Palmer-Toy; Mark G Erlander; Dennis C Sgroi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

10.  Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.

Authors:  Jorge S Reis-Filho; Pete T Simpson; Albino Martins; Ana Preto; Fátima Gärtner; Fernando C Schmitt
Journal:  Virchows Arch       Date:  2003-07-16       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.